Login / Signup

Genomic Analysis of AZD1222 (ChAdOx1) Vaccine Breakthrough Infections in the City of Mumbai.

Arusha ShettyGaurav ChatterjeeSweta RajpalTuhina SrivastavaNilesh GardiSumeet Prakash MirghAnant GokarnSachin PunatarNitin Sudhakar ShettyAmit JoshiSudhir NairVedang MurthyNavin KhattryPrashant Ramesh TembhareRajesh P DikshitPankaj ChaturvediAshwini MoreSujeet KamtalwarPreeti ChavanVivek BhatAmar PatilSachin DhumalPrashant BhatPapagudi SubramanianSumeet GujralRajendra BadweNikhil V PatkarSudeep Gupta
Published in: International journal of clinical practice (2022)
Sequencing analysis of SARS-COV-2 genomes from Mumbai during the second wave of COVID-19 suggests the prevalence of the kappa B.1.617.1 and the delta B.1.627.2 variants among both vaccinated and unvaccinated individuals. Continued evaluation of genomic sequencing data from breakthrough COVID-19 is necessary for monitoring the properties of evolving variants of concern and formulating appropriate immune response boosting and therapeutic strategies.
Keyphrases
  • sars cov
  • copy number
  • immune response
  • coronavirus disease
  • respiratory syndrome coronavirus
  • single cell
  • risk factors
  • electronic health record
  • dendritic cells
  • deep learning